We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RSG icon
76
Republic Services
RSG
$64.5B
$58.5M 0.36%
675,728
+669,264
+10,354% +$55.7M
AVTR icon
77
Avantor
AVTR
$8.91B
$56.2M 0.35%
+2,942,143
New +$52.4M
CRM icon
78
Salesforce
CRM
$153B
$55.5M 0.34%
365,616
+296,755
+431% +$46.5M
DG icon
79
Dollar General
DG
$28.1B
$55.2M 0.34%
408,214
+243,258
+147% +$30.7M
JPM icon
80
JPMorgan Chase
JPM
$947B
$54.1M 0.34%
483,698
-165,936
-26% -$18.3M
A icon
81
Agilent Technologies
A
$39.9B
$53.5M 0.33%
716,822
-338,258
-32% -$25.1M
ABBV icon
82
AbbVie
ABBV
$431B
$53.2M 0.33%
732,006
+473,892
+184% +$37.2M
EBAY icon
83
eBay
EBAY
$48.9B
$52.9M 0.33%
1,340,306
+418,444
+45% +$15.7M
CSCO icon
84
Cisco
CSCO
$476B
$52.4M 0.33%
+956,853
New +$52.8M
SWK icon
85
Stanley Black & Decker
SWK
$15.3B
$51.3M 0.32%
354,871
+333,308
+1,546% +$47M
FICO icon
86
Fair Isaac
FICO
$22.3B
$50.2M 0.31%
159,743
-96,393
-38% -$28M
MPC icon
87
Marathon Petroleum
MPC
$84B
$49.7M 0.31%
888,991
+230,906
+35% +$12.6M
MA icon
88
Mastercard
MA
$505B
$49.6M 0.31%
187,501
-244,589
-57% -$61.2M
ITW icon
89
Illinois Tool Works
ITW
$84.8B
$49.1M 0.3%
325,750
+178,353
+121% +$26.9M
HON icon
90
Honeywell
HON
$76.3B
$49M 0.3%
297,551
+121,462
+69% +$19.3M
ALXN
91
DELISTED
Alexion Pharmaceuticals
ALXN
$48.1M 0.3%
367,354
-248,883
-40% -$32.1M
ROST icon
92
Ross Stores
ROST
$81.6B
$46.5M 0.29%
468,998
-66,367
-12% -$6.47M
BMRN icon
93
BioMarin Pharmaceuticals
BMRN
$11.9B
$46.3M 0.29%
540,205
+135,130
+33% +$11.6M
AXP icon
94
American Express
AXP
$231B
$45.1M 0.28%
365,562
+350,728
+2,364% +$41.2M
ROL icon
95
Rollins
ROL
$17.7B
$43M 0.27%
1,798,916
+454,667
+34% +$11.7M
AMT icon
96
American Tower
AMT
$79.8B
$43M 0.27%
210,287
+207,187
+6,683% +$41.6M
ASH icon
97
Ashland
ASH
$3.32B
$42.9M 0.27%
536,249
+79,237
+17% +$6.12M
CMCSA icon
98
Comcast
CMCSA
$89.3B
$42.1M 0.26%
995,646
+267,404
+37% +$11.3M
GPK icon
99
Graphic Packaging
GPK
$3.51B
$42M 0.26%
3,006,131
+1,193,788
+66% +$16M
TDG icon
100
TransDigm Group
TDG
$69.8B
$41M 0.25%
84,651
-17,160
-17% -$8.03M
2 3
4
5 6

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.